Joseph L Kuti

26PUBLICATIONS
32CO-AUTHORS
Medical bacteriologyInfectious agentsDisease surveillancePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 03, 2025
Clinical impact of BioFire Blood Culture Identification 2 implementation in patients with Staphylococcus bacteremia.

Colin H Duell, Tyler Ackley, Kristin E Linder

|Jun 17, 2025
Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading.

Joseph L Kuti, Joseph D Lutgring, Patricia J Simner

|May 20, 2025
Impact of an electronic antibiotic time-out best practice alert on antibiotic use and prescribing behavior in hospitalized patients.

Tyler Ackley, Joseph Kuti, Anastasia Bilinskaya

|May 15, 2025
Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Wesley D Kufel, Nabil Zeineddine, Aliaa Fouad

|May 12, 2025
Predictive performance of population pharmacokinetic models in InsightRX® for model-informed precision dosing for Cefepime.

Christina König, Joseph L Kuti, Andrew J Fratoni

|May 05, 2025
Ex vivo assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapy.

Aliaa Fouad, Cole McGrath, Ecem Buyukyanbolu

Pageof 5

Frequent Collaborators

12 joint publications

David P Nicolau

2 joint publications

Tyler Ackley

2 joint publications

Lisa T Hong

2 joint publications

Kevin J Downes